Pharmaceutical Development and Technology最新文献

筛选
英文 中文
Development and biological evaluation of a Cotinus coggygria extract-loaded Pluronic F127-HPMC buccal gel formulation. 载Pluronic F127-HPMC口腔凝胶制剂的研制及生物学评价。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-07-01 Epub Date: 2026-08-05 DOI: 10.1080/10837450.2026.2707530
Hayrullah Pakkan, Zehra Keskin, Hümeyra Şahin Bektay, Gülbahar Özge Alim Toraman, Fatma Göç, Zeynep Büşra Erarslan, Ali Asram Sağıroğlu, Meltem Güleç, Gülaçtı Topçu, Aysenur Gunaydin Akyildiz
{"title":"Development and biological evaluation of a <i>Cotinus coggygria</i> extract-loaded Pluronic F127-HPMC buccal gel formulation.","authors":"Hayrullah Pakkan, Zehra Keskin, Hümeyra Şahin Bektay, Gülbahar Özge Alim Toraman, Fatma Göç, Zeynep Büşra Erarslan, Ali Asram Sağıroğlu, Meltem Güleç, Gülaçtı Topçu, Aysenur Gunaydin Akyildiz","doi":"10.1080/10837450.2026.2707530","DOIUrl":"10.1080/10837450.2026.2707530","url":null,"abstract":"<p><p><i>Cotinus coggygria</i> Scop. is a polyphenol-rich medicinal plant traditionally used in topical preparations, and the formulation-dependent effects of its extracts on fibroblast behavior remain insufficiently characterized. In this study, a 60% ethanol extract of <i>C. coggygria</i> was prepared and chemically profiled by LC-HRMS, identifying 6-OH-luteolin-7-O-glucoside as a major constituent. <i>In silico</i> bioactivity prediction of this compound indicated the highest mean probability of activity within the membrane/barrier-associated category (mean Pa = 0.895). An optimized Pluronic F127-HPMC gel formulation incorporating the extract was developed and evaluated using human fibroblasts as an <i>in vitro</i> screening model. Intracellular ATP levels were measured to examine potential effects on cellular bioenergetics, and cell migration was assessed by scratch assay. Within the tested concentration range (5-15 µg/mL), treatment with the extract-loaded gel resulted in reduced intracellular ATP levels by 25% and decreased migration modestly, whereas the extract alone did not significantly alter these parameters, indicating a formulation-dependent modulation of cellular response. In an exploratory <i>Caenorhabditis elegans</i> assay, the extract exhibited a biphasic concentration-dependent response, with the lowest concentration tested (3 µg/mL) producing the greatest lifespan extension, whereas higher concentrations (3000-50 000 µg/mL) progressively reduced survival. Collectively, these findings demonstrate that incorporation of <i>C. coggygria</i> extract into a gel matrix alters cellular bioenergetics and motility.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1071-1089"},"PeriodicalIF":2.9,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148550060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thermosensitive hydrogels for sustained semaglutide release: overcoming weight loss plateau in diet-induced obese rats. 用于持续释放西马鲁肽的热敏水凝胶:克服饮食诱导的肥胖大鼠的体重减轻平台期。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-07-01 Epub Date: 2026-07-20 DOI: 10.1080/10837450.2026.2703559
Jing Wang, Hong Hu, Luoxin Long, Hanyu Wan, Jiatong Lv, Yi Yan, Yuji Wang, Shanhong Mao
{"title":"Thermosensitive hydrogels for sustained semaglutide release: overcoming weight loss plateau in diet-induced obese rats.","authors":"Jing Wang, Hong Hu, Luoxin Long, Hanyu Wan, Jiatong Lv, Yi Yan, Yuji Wang, Shanhong Mao","doi":"10.1080/10837450.2026.2703559","DOIUrl":"10.1080/10837450.2026.2703559","url":null,"abstract":"<p><p>A series of semaglutide-loaded sustained-release formulations is developed using thermosensitive hydrogel as the release system. Micro-needle jet injection (MNJI) devices are used to deliver the highly viscous material and achieve a desired dispersion at delivery. Physicochemical properties, <i>in vitro</i> drug release behavior, and biocompatibility are systematically characterized. Therapeutic efficacy is evaluated in DIO rats, with non-sustained formulation as control to assess efficacy and sustainability. P407-based hydrogel has temperature-dependent sol-gel transition: at low temperature it is injectable, while at body temperature it becomes a solid gel to restrict semaglutide release. Drug incorporation did not interfere with this property. MNJI devices effectively delivered the formulation with consistency and showed favorable safety without severe inflammation. The system prolonged half-life to 15 h, extended Tmax from 8 to 24 h, and maintained effective levels to day 6. In DIO rats, GT10 50 achieved continuous weight loss over 20 days, overcoming the plateau of non-sustained formulations. Serum assays revealed significant reductions in TC (<i>p</i> < 0.01), ALT (<i>p</i> < 0.05), and AST (<i>p</i> < 0.01), indicating improved dyslipidemia and liver injury. Glucose tolerance tests confirmed alleviation of hyperglycemia without hypoglycemia. This study provides a strategy for obesity management with good efficacy and improved compliance <i>via</i> reduced dosing.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1003-1019"},"PeriodicalIF":2.9,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148448694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repurposing simvastatin with piperine through β-cyclodextrin inclusion complex: a dual-drug strategy to enhance solubility and antiproliferative activity in hepatic cancer cells. 辛伐他汀与胡椒碱通过β-环糊精包合物的再利用:提高肝癌细胞溶解度和抗增殖活性的双药策略。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-07-01 Epub Date: 2026-07-24 DOI: 10.1080/10837450.2026.2706520
Riyad F Alzhrani, Syed Sarim Imam, Sultan Alshehri, Wael A Mahdi, Saad Alobid, Mohammed A Assiri, Gamaleldin I Harisa
{"title":"Repurposing simvastatin with piperine through β-cyclodextrin inclusion complex: a dual-drug strategy to enhance solubility and antiproliferative activity in hepatic cancer cells.","authors":"Riyad F Alzhrani, Syed Sarim Imam, Sultan Alshehri, Wael A Mahdi, Saad Alobid, Mohammed A Assiri, Gamaleldin I Harisa","doi":"10.1080/10837450.2026.2706520","DOIUrl":"10.1080/10837450.2026.2706520","url":null,"abstract":"<p><p>The purpose of this feasibility study was to develop a co-delivery inclusion complex of Simvastatin (SIM) and Piperine (PIP) using different cyclodextrins to enhance solubility and evaluate its antiproliferative activity in hepatocellular carcinoma (HCC) cells. SIM has recently been repurposed as a potential anticancer agent; however, its low bioactivity is mainly driven by its poor aqueous solubility. SIM and PIP inclusion complexes were prepared using Beta-cyclodextrin (βCD), Methyl β-cyclodextrin (M βCD), and Hydroxypropyl β-cyclodextrin (HP βCD) <i>via</i> solvent evaporation (SE) and microwave irradiation (MI). Phase solubility studies revealed AL-type profiles, with a higher stability constant for M βCD. The optimized ternary complex PIP-SIM-M βCD (F6-SE) increased the solubility of PIP and SIM to 708.58 ± 19.1 and 127.1 ± 4.9 µg/mL, respectively. <i>In vitro</i> cytotoxicity studies demonstrated that the PIP-SIM-M βCD complex significantly inhibited HepG2 cell viability. Apoptosis data indicated a higher proportion of late apoptotic cells and suggested G1 phase arrest. Overall, these findings support the use of M βCD-based inclusion complexes as a promising formulation strategy for co-delivering SIM and PIP and enhancing their <i>in vitro</i> antiproliferative activity in liver cancer cells.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1020-1032"},"PeriodicalIF":2.9,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148520801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent progress in nanoparticulate lipid-based co-delivery systems containing gene-based cargoes for the treatment of oncological and non-oncological diseases. 含有基因载体的纳米颗粒脂质共递送系统用于治疗肿瘤和非肿瘤疾病的最新进展。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-06-01 Epub Date: 2026-07-15 DOI: 10.1080/10837450.2026.2686958
Reza HosseinPour-Moghadam, Sima Sadrai, Tayebeh Toliyat
{"title":"Recent progress in nanoparticulate lipid-based co-delivery systems containing gene-based cargoes for the treatment of oncological and non-oncological diseases.","authors":"Reza HosseinPour-Moghadam, Sima Sadrai, Tayebeh Toliyat","doi":"10.1080/10837450.2026.2686958","DOIUrl":"10.1080/10837450.2026.2686958","url":null,"abstract":"<p><p>Lipid-based nanoparticulate systems provide a versatile and multifaceted platform that directly addresses critical drug delivery challenges. By encapsulating a diverse spectrum of therapeutic agents, these systems significantly enhance biocompatibility, improve bioavailability, and ensure superior stability, thereby maximizing therapeutic potential. These systems can act as non-viral vectors for successful delivery of gene-based molecules to required sites and provide the desired therapeutic effects. Conversely, the implementation of a co-delivery strategy for both oncological and non-oncological conditions holds significant promise for substantially improving clinical outcomes, and one of the main platforms for achieving synergistic effects is employing lipid-based systems. This article aims to review the recent progress in co-delivery approaches by employing lipid-based delivery systems containing gene-based cargoes.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"820-861"},"PeriodicalIF":2.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148448718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strategies for inhibiting the burst release effect in peptide long-acting release delivery systems. 抑制肽长效释放系统中爆发释放效应的策略。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-06-01 Epub Date: 2026-05-23 DOI: 10.1080/10837450.2026.2669967
Xianhua Zhang, Yuanlei Fu, Yuan Tan, Dongfang Cheng, Xiuzhi Wang, Baohua Niu, Ling Ni, Weijing Luan, Teng Liu
{"title":"Strategies for inhibiting the burst release effect in peptide long-acting release delivery systems.","authors":"Xianhua Zhang, Yuanlei Fu, Yuan Tan, Dongfang Cheng, Xiuzhi Wang, Baohua Niu, Ling Ni, Weijing Luan, Teng Liu","doi":"10.1080/10837450.2026.2669967","DOIUrl":"10.1080/10837450.2026.2669967","url":null,"abstract":"<p><p>Peptide medications are essential for the treatment of numerous illnesses and offer several benefits, including minimal toxicity and excellent specificity. Nevertheless, issues including peptide medicines' short <i>in vivo</i> half-life and poor oral bioavailability have significantly restricted the clinical use of many peptide medications with lengthy therapy cycles. Extended single injection cycles and fewer injections are possible with long-acting formulations. <i>In situ</i> gel and microsphere formulations are among the most promising for the long-acting administration of peptide drugs; however, the burst release effect that occurs during the initial stage of administration of these two formulations may raise the risk of adverse drug reactions, making this a critical problem that requires immediate attention. With the goal of providing a thorough theoretical foundation and useful advice for the optimization of the performance of these two types of long-acting injections, as well as encouraging the advancement of the technology of long-acting administration of peptide drugs, this paper examines the causes of the burst release effect of <i>in situ</i> gel and microsphere formulations from the physicochemical properties of peptide drugs, polymer matrix, solvent, and preparation process, among other aspects. Additionally, it seeks to increase patient drug compliance and the effectiveness of peptide medications.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"711-728"},"PeriodicalIF":2.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147988654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rutin-loaded film-forming spray for accelerated wound repair: a QbD-guided translational approach. “芦丁负载成膜喷雾加速伤口修复:qbd引导的翻译方法”。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-06-01 Epub Date: 2026-06-23 DOI: 10.1080/10837450.2026.2682783
Preeti Karwa, Ayesha Syed, Sohal Mallick, Mohd Osama Nabi
{"title":"Rutin-loaded film-forming spray for accelerated wound repair: a QbD-guided translational approach.","authors":"Preeti Karwa, Ayesha Syed, Sohal Mallick, Mohd Osama Nabi","doi":"10.1080/10837450.2026.2682783","DOIUrl":"10.1080/10837450.2026.2682783","url":null,"abstract":"<p><p>Wound healing remains a major clinical challenge, necessitating advanced topical systems that accelerate repair while minimizing complications. Rutin, a flavonoid with potent antioxidant, anti-inflammatory and angiogenic properties, suffers from poor solubility and instability, limiting therapeutic application. To overcome these drawbacks, a rutin-loaded film-forming spray (FFS) was developed using a Quality by Design (QbD) framework and optimized <i>via</i> a Box-Behnken design. Eudragit<sup>®</sup> RLPO and Eudragit<sup>®</sup> E100 were employed as film-forming polymers, propylene glycol as a plasticizer, and menthol as a permeation enhancer. The optimized formulation, CO-RUT (F1), exhibited favorable physicochemical characteristics, including rapid drying (56 ± 2 s), suitable viscosity (3.8 ± 0.076 cPs), and uniform drug content (95.3% ± 2%). <i>In vitro</i> release demonstrated sustained delivery over 8 h (86.7% ± 1.6%), following Korsmeyer-Peppas kinetics indicative of anomalous diffusion. <i>Ex vivo</i> permeation achieved 97.8% cumulative permeation, attributed to the synergistic effects of menthol and propylene glycol. Most critically, <i>in vivo</i> wound healing studies in rats showed complete wound closure by day 16, significantly outperforming marketed formulations and controls. Histopathological examination confirmed superior epithelialization, collagen deposition, and angiogenesis. The CO-RUT (F1) formulation which integrates QbD principles with robust experimental design demonstrates strong translational potential as a novel wound-healing platform and provides a methodological framework for developing next-generation film-forming sprays.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"794-819"},"PeriodicalIF":2.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148138744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bortezomib/SBE-β-cyclodextrin inclusion complex for improved anticancer performance: formulation, characterization, and biological evaluation. 硼替佐米/SBE-β-环糊精包合物用于提高抗癌性能:配方、表征和生物学评价。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-06-01 Epub Date: 2026-06-02 DOI: 10.1080/10837450.2026.2673573
Saber Hakiminasab, Mohammad Mashreghi, Bizhan Malaekeh-Nikouei, Seyedeh Hoda Alavizadeh, Shiva Golmohammadzadeh, Leila Arabi, Fatemeh Akbarzadeh-Ebrahimi, Mahmoud Reza Jaafari
{"title":"Bortezomib/SBE-β-cyclodextrin inclusion complex for improved anticancer performance: formulation, characterization, and biological evaluation.","authors":"Saber Hakiminasab, Mohammad Mashreghi, Bizhan Malaekeh-Nikouei, Seyedeh Hoda Alavizadeh, Shiva Golmohammadzadeh, Leila Arabi, Fatemeh Akbarzadeh-Ebrahimi, Mahmoud Reza Jaafari","doi":"10.1080/10837450.2026.2673573","DOIUrl":"10.1080/10837450.2026.2673573","url":null,"abstract":"<p><p>Bortezomib (BTZ) is a potent anticancer agent whose clinical application is limited by poor aqueous solubility. We engineered a sulfobutylether-β-cyclodextrin (SBE-β-CD) inclusion complex <i>via</i> aqueous complexation and freeze-drying to enhance BTZ solubility and therapeutic performance. Phase solubility analysis demonstrated a 25.7-fold increase in BTZ solubility at a 1:20 molar ratio (F1), in 25 °C. Complex formation was confirmed by differential scanning calorimetry (DSC) and Fourier-transform infrared (FTIR) spectroscopy. The F1 formulation exhibited sustained drug release at physiological pH of 7.4. Although F1 showed slightly reduced <i>in vitro</i> cytotoxicity compared with conventional BTZ (cBTZ) in C26 and U266 cell lines, it significantly improved <i>in vivo</i> antitumor efficacy in C26 tumor-bearing mice, achieving a tumor growth delay (TGD) of 52.14% versus 29.34% for cBTZ. Furthermore, a calcein/SBE-β-CD complex (F1', 1:20 molar ratio, as a fluorescent model drug) demonstrated enhanced cellular uptake and tumor accumulation in C26 tumor-bearing mice. These findings highlight SBE-β-CD as a promising platform for BTZ encapsulation, enabling improved drug delivery and anticancer efficacy and merits further investigation.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"764-777"},"PeriodicalIF":2.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148138708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intranasal mucoadhesive biomaterials for nose-to-brain neuroactive delivery: platform design and model-informed translation for time-bounded CNS exposure. 鼻-脑神经传递的鼻内黏附生物材料:平台设计和有时间限制的中枢神经系统暴露的模型信息翻译。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-06-01 Epub Date: 2026-07-03 DOI: 10.1080/10837450.2026.2689058
Tae-Yoon Kim, Jung-Hyun Kim
{"title":"Intranasal mucoadhesive biomaterials for nose-to-brain neuroactive delivery: platform design and model-informed translation for time-bounded CNS exposure.","authors":"Tae-Yoon Kim, Jung-Hyun Kim","doi":"10.1080/10837450.2026.2689058","DOIUrl":"10.1080/10837450.2026.2689058","url":null,"abstract":"<p><p>Intranasal nose-to-brain delivery remains difficult to translate because regional deposition, mucociliary clearance, epithelial transport, local instability, tolerability feedback, and systemic absorption jointly determine central nervous system (CNS) exposure. This evidence-mapping review evaluates mucoadhesive biomaterial platforms as formulation-development tools for improving residence, release control, deposition reproducibility, and exposure interpretability in neuroactive intranasal delivery, using insomnia-relevant timing requirements as a stringent case for controlled onset and offset. PubMed/MEDLINE, Embase, Web of Science Core Collection, and Scopus were searched from 1 January 2008 to 30 April 2026. Seventeen primary intranasal platform studies were included; route-attribution credibility was high in five studies, moderate in five, low in six, and not assessable in one. Platform classes included <i>in situ</i> gelling depots, pre-formed gels, polymeric nanoparticles, lipid or vesicular carriers, hybrid nanoparticle-in-gel systems, and device-coupled dry powders. Key formulation variables were translated into development endpoints, including rheology, gelation, mucoadhesion, release kinetics, deposition, permeability, systemic leakage, and nasal tolerability. The proposed model-informed strategies are conceptual; no new physiologically based pharmacokinetic simulations were performed. Successful platforms should be judged by reproducible onset, controlled offset, bounded systemic exposure, and recovery-phase safety rather than by peak brain concentrations or targeting ratios alone.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"862-876"},"PeriodicalIF":2.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148252759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Capryol-ethyl oleate self-microemulsifying system for improved intestinal absorption and hypoglycemic activity of empagliflozin. 改善恩格列净肠道吸收和降血糖活性的油酸辛醇-乙酯自微乳化系统。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-06-01 Epub Date: 2026-05-20 DOI: 10.1080/10837450.2026.2674731
Eglal M Hathout, Suleiman S Eltokhy, Dalia H Abdelkader, Gamal M El Maghraby
{"title":"Capryol-ethyl oleate self-microemulsifying system for improved intestinal absorption and hypoglycemic activity of empagliflozin.","authors":"Eglal M Hathout, Suleiman S Eltokhy, Dalia H Abdelkader, Gamal M El Maghraby","doi":"10.1080/10837450.2026.2674731","DOIUrl":"10.1080/10837450.2026.2674731","url":null,"abstract":"<p><p>Empagliflozin (EMPA) is a poorly permeable oral hypoglycemic agent. It is potential substrate for P-glycoprotein (P-gp). This work assessed the impact of anatomical sites on EMPA intestinal absorption and assessed self-microemulsifying drug delivery systems (SMEDDS) as a novel strategy for augmented intestinal permeability and oral hypoglycemia of EMPA. A pseudo-ternary phase diagram was used to select a nano-formulation encompassing 60% tween 60: 30% transcutol: 5% capryol: 5% ethyl oleate. This was characterized for droplet size which was 31.2 nm, PDI was 0.292, and zeta potential which was -1.2 mV. EMPA absorption was assessed using <i>in situ</i> intestinal absorption, and the system was evaluated <i>in vivo</i> using diabetic rats. <i>In situ</i> intestinal absorption studies from aqueous solutions demonstrated poor permeability of EMPA from all tested segments relating to the regional distribution of P-gp efflux transporters. Perfusion of EMPA as microemulsion resulting from reconstitution of SMEDDS enhanced ileal and colonic absorption by 1.9 and 1.85-fold, respectively. Furthermore, <i>in vivo</i> studies demonstrated significant augmentation in oral hypoglycemic activity of EMPA, revealed as 1.45-fold elevation in area under blood glucose reduction curve after administration of SMEDDS compared to EMPA aqueous dispersion. SMEDDS formulation successfully improved intestinal absorption, hypoglycemic efficacy and hence oral bioavailability of EMPA.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"778-793"},"PeriodicalIF":2.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147960203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mixture design-modelling and optimization of ketoprofen solid lipid nanoparticles for augmented anti-inflammatory activity following pharmacodynamic evaluation in rats. 酮洛芬固体脂质纳米颗粒增强大鼠抗炎活性的混合物设计建模和优化。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-06-01 Epub Date: 2026-05-31 DOI: 10.1080/10837450.2026.2673037
Amal Abdullah Alrashidi, Mostafa M Bahaa, Esmat E Zain Eldein, Ahmed M Abdelhaleem Ali, Mohamed A Etman, Heba A Yassin
{"title":"Mixture design-modelling and optimization of ketoprofen solid lipid nanoparticles for augmented anti-inflammatory activity following pharmacodynamic evaluation in rats.","authors":"Amal Abdullah Alrashidi, Mostafa M Bahaa, Esmat E Zain Eldein, Ahmed M Abdelhaleem Ali, Mohamed A Etman, Heba A Yassin","doi":"10.1080/10837450.2026.2673037","DOIUrl":"10.1080/10837450.2026.2673037","url":null,"abstract":"<p><p>Topical administration of non-steroidal anti-inflammatory drugs (NSAIDs) is often limited by poor skin permeability and short duration of action. Solid lipid nanoparticles (SLNs) offer a promising carrier system to enhance dermal delivery and sustain local therapeutic effects. This study aimed to formulate and optimize ketoprofen (KP)-loaded SLNs to improve its efficacy in topical inflammatory conditions. A mixture design was applied for modeling and optimization of formulation variables. SLNs were prepared using hot melting and solvent evaporation techniques and characterized for particle size, polydispersity index (PDI), zeta potential, entrapment efficiency, and drug release. Pharmacodynamic evaluation was conducted using a carrageenan-induced paw edema model in rats, compared with a marketed formulation (FASTUM gel 2.5%). The optimized SLNs showed a particle size of 51.9±4.55 nm, PDI of 0.398±0.02, and zeta potential of -14.2±0.61 mV, indicating acceptable stability. The optimized formulation significantly reduced paw edema by 57.65% and decreased PGE2 and TNF-α levels by 55.6% and 58.4%, respectively (P < 0.05). Additionally, the SLN gel exhibited enhanced bioadhesion (+81%) and doubled permeation flux compared to the pure drug gel. These findings support SLNs as an effective platform for topical NSAID delivery.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"744-763"},"PeriodicalIF":2.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147942358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书